Exploring the unknown.
Pioneering for Patients.

About Galapagos

Galapagos discovers, develops and commercializes novel medicines in the field of inflammation, fibrosis and kidney diseases

Galapagos is a pioneering biotech with a pipeline of innovative therapies to address unmet medical needs.

On track to become a leading European biotech


22 years
 of ground-breaking research and development


10 years
 partnership formed with Gilead in 2019

An increasing global reach


 Over 1300 
employees globally


International locations 

R&D is at the heart of our business


 of employees work in R&D


 of operating expenses are in R&D

One of biotech’s largest pipelines of medicines with novel modes of action


65 patient families owned


Over 45 
drug candidates discovered


Up to 50% 
of drug candidates in clinical development

Targeting a range of conditions, including these underserved diseases

IBD (2021)

Our History

Galapagos’ mission is to develop first-in-class medicines based on the discovery of novel targets. Galapagos researchers have gone from target to proof of concept in three lead programs addressing broad disease categories affecting millions worldwide.

Using human primary cells and patient cells, the company discovers which proteins ("targets") play a key role in causing diseases such as rheumatoid arthritis, inflammatory bowel disease, fibrosis and kidney disease. Galapagos then aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease. This approach addresses the disease itself rather than just treating the symptoms.

Galapagos' aim is to make a lasting positive contribution to society through discovery of breakthrough therapies for diseases with large unmet need.


Clinical Trials

Galapagos conducts Phase 1 trials in healthy volunteers in centers which are specifically equipped for this purpose, with the aim to test the safety, tolerability and …


We’re not only looking for scientists. We’re looking for pioneers in a wide range of domains: The best-in-class doctors, …

Corporate Responsibility

Our commitment to Corporate Social Responsibility (CSR) is intrinsically linked to our core mission: to discover and develop …